DOCSLIB.ORG

BRIEF NOTE Phenotypic Drug Adaptation in Mucor

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BRIEF NOTE Phenotypic Drug Adaptation in Mucor EXI'IlItIMEN1AL MYCOLOGY 12, 284-2HH (lYHH) 6083 * BRIEF NOTE Phenotypic Drug Adaptation in Mucor racemosus: Constitutively Adapted and Nonadaptive Mutants JULIUS PETERSI.~ AND TIMOTHY D. LEATHERS' DcparfltU"11 of Microbiolof.:Y alld Molecular G('lIf.'fk.~. Culij"(l/'flia CO/lq.:l' (~r Aft<di<'illl'. Ullh'l'rsiry o[Ca/ijim,j{I. Jl'l'ine. Ca/(fomillY27J7 Accepted for publication December 6. 19B7 PETERS, J.. AND LEATHERS. T. D. 1988. Phenotypic drug adaptiltion in Mucor 1'(1C('r1//lSIf5: Con· stilulively adapted and nonadaptive mutants. Experimelllt1J A-fyrolo~y. 12, 284-2HK. WilLi·type Mucor racemoSliS acquires phenotypic resistance to cycioheximiLic after a characteristic lug peri~ od. Adapted culturcs are cross·resislant to the unrelalcd drugs trichndcrmin and amphotericin B. Mutants were isolated as either constitutively resistant (COR mut;.mtsl or nonlldaptive (NAD mutants) to cycloheximide. Mutant COR 2A was constitutively resislant 10 cycloheximide <.llone. and <.ldapted normally to trichodermin and amphotericin B. Mulant COR JA was cunstitutivdy resistant to both cycloheximide and lrichodermin. and had partially induced resi"tance 10 ampho· tericin B. Mutant NAD 67 was also pleiolropic. as it was unable 10 adilpt to any llf lhcse drugs. Phenotypic drug adaptation in M. racellfOSIiS thus appears to involve bOlh general and l.1rug·"pecific components. 1" 191\11 AC:;ldtmic: Prts~. Inc:. INDEX DESCRIPTORS: drug resistance: phenotypic adaptation: Mucor ran'/IIo.Hls: cycloheximide: trichmlt:rmin: amphotericin B; antibiotics; fungicides. Phenotypic adaptation to antifungal coordinately involves the entire fungal pop­ agents has been described for a wide vari­ ulation (Sypherd el al., 1979). For similar ety of fungi. including the phytopathogens reasons. M. rac£'lIlosus promises to serve Sclerolillia fruclicola (Grover and Moore. as an advantageous system for the study of 1981) and Usti/a'iO lIla)'dis (Esposito and phenotypic adaptation. High-level drug re­ Holiday, 1964). and the human pathogens sistance was found to be inducible in a sin­ Cryptococcus lIeo!orlllGIIS (Bodenhoff. gle step. and coordinately involved the en­ 1968) and Clllldida albicalls (Notario £'1 al., tire fungal population. M. mcelllO.HlS devel­ 1982). Recently, drug adaptation was de­ oped phenolypic resistance to drugs (,I' scribed in the dimorphic fungus Mucor dissimilar struclures and modes of action. raC£'IIlOS/lS (Leathers and Sypherd. 1985). specifically cycloheximide. lrithodermin. !vI. rUCl'11IOSUS has long serveu as un atlrac­ and amphotericin ll. Furlhermore. adapta­ tive model for the study of fungal dimor­ tion to a single drug induced cross­ phism; morphogenesis in Ihis species is resistance to unrelated drugs. Patterns of unique in that it is easily manipulated and cross-resistance suggested that a general mechanism might function in phenotypic I To whom correspondence should \1c addressed. resistance. for example a nonspecific ex­ ~ Current address: Clinical Microhiology Laboralo­ port system. Such a resistance mechanism ry. Children's Hospital or Los Angclcs. University of could have serious implicalions for the ag­ Southern Californiu School of Medicine. Los Angeles. ricultural and clinical control of fungi. CA Y0054. :\ Current adtlre"s: Northern Regional Research More recently. an inducible trichodermin Cenler. U.S. Deparlment of Agriculture. Pcmill. IL dCloxificalion mechanism was clucicJalcd in 61604. M. rIICl'II/O.\·/I.\' (Fonzi and Sypherd. 1986). 2K4 0147·5Y7.1/HH ~).OO ('Uf'yrijll11 1- I!JIII( hr A,;;"kllliL: 1'1<"\, 1m: All nl:hl\ III ft'f'I\'lh'l'lwll in 1m) h'llI} Il'\I'rn'd DRUG AOAllTATION MUTANTS OF M, rlln'IT/I1.HU 285 The apparent spedlicity of this mechanism tively resistant>. A eomplementary non­ (dea<.:etylation of tri<.:hodermin hy an es­ udaplive class wus also sought (NAD mu­ terase) has raised questions <.:on<.:erning the lants. for nonadaptive to drugs>. plausibility of a general me<.:hanism of drug Nitrosoquanidine-mutagenized sporan­ adaptation. An important prediction of a giospores of M. mall/oSlls were subjected general resistan<.:e model is that drug­ to one of two regimes. A simple direct se­ adaptive mutants would be pleiotropic. i.e.. lection wus possible for constitutive (COR) altered in responses to more than one drug. mutants. Mutugenized spores were germi-. We des<.:ribe here the tirst isolation of drug­ nated on solid medium unaerobically in the adaptive mutants of M. J'ace/llUSIiS. presence of ZOO fJ.g/ml cycloheximide. Un­ M. J'ace/ll(lSl/S (synonym M. {IiSillil/iclis. treated spores produced colonies under strain ATCC 1216B. NRRl 3631) served as these conditions only after a lag period of the wild type. Details of culture mainte­ 100 to 150 h. C"lonies that urose earlier nan<.:e and grow(h have been described (Pe­ than 100 h were wnsidered putative COR ters and Sypherd. In8>. Growth medium mut'lnts. These were purilied and scored on for both liquid cultures and plates was 0.5% cycloheximide plates alongside wild-type peptone. 0.05% yeast nitrogen base. and controls. 2.0% glucose. A more complicated procedure involving Anaerobic liquid cultures for adaptation counterselection wus required to obtain cy­ growth curves were sparged with 100% CO2 cloheximide-sensitive (NAD) mutants. Mu­ at 0.5 vol!culture vol/min. and were rotary tagenized spores were inoculated into liq­ shaken at 100 rmp and at 25"C. Culture uid cultures spurged with nitrogen (0.5 vol! growth was followed with a Klett­ culture vol/min) in the presence of 100 Summerson colorimeter with a green tilter fJ.g/ml cycloheximide. Under these condi­ (540. nm). Anaerobic incubations of solid tions. untreated spores coordinately medium cultures were in CO2-enriched formed hyphal "germlings" following an BBl Gas-Pak chumbers (Becton­ adaptive lag period of approximately 24 h. Dickinson and Co.. Cockeysville.. MD>. After 48 h of incubation. mutugenized cul­ Anaerobic conditions resulted in the yeast­ tures were enriched for ungerminated like morphology of M. mce/ll()SlIs. While spores by tiltration through Miraelo·th. Fil­ this morphology has obvious manipulative trates were subjected to further counterse­ advantages. the mycelial form also under­ lection against germlings by the freeze­ goes phenotypic uduptation. as previously thaw method of Peters and Sypherd (1978). described (leathers und Sypherd. 1985). (U ngerminated spores ure more resistant to Peptone and yeast nitrogen base were freeze-thawing.) Following three rounds of from Difco luboratories. Detroit. Michi­ germination. enrichment. and counterselec­ gan. Cycloheximide wus from Sigma Chem­ tion. viuble spores were selected by pluting ical Co.. St. louis. Missouri. Amphoteri<.:in on drug-free anuerohic solid medium. to B was from E. R. Squibb and Sons. Prince­ form yeastlikc colonies. After single-colony ton. New Jersey. Other chemicals were re­ purilication on drug-free plates. putative agent grade. mutants were scored on replica pi utes con­ Isolation ofmlltlints deft!('til,.'e in drug mi· taining ZOO fJ.g/ml cycloheximide. aplaliol/. Two classes of mutunts were Quantittah'e linalysis of llduptatilJ11 and sought. Since phenotypic aduptation nor­ cToss·,-esistlince in mutlints. Drug gr:owrh mally occurs only after a characteristic in­ response curves were determined for Ii'quid duction lag period. mutants were selected cultures grown in the yeastlike form. Fig­ for uninduced (constitutive) resistance to ures IA through 10 compure wild-type M. cycloheximide (COR mutants. for constitu- mcemoSlls with three representative mu- E:RRATA Panels of Fig. 1 are out of order, and consequently misidentified in figure legends and in accompanying text. Corrected Legend: Legend to Fig. 1: Adaptive response of tl. racemosus strains to drugs. Early exponential cultures were split at time 0 and challenged with drugs. (A) Cycloheximide constitutively resistant mutant COR 3A; (B) Cycloheximide constitutively resistant mutant COR 2A; (C) Wild-type strain; (D) cycloheximide nonadaptive mutant NAD 67. Corrected Text: p. 287, 1. 1 : "Fig. 1A" should read "Fig. leI! p. 287, 1. 5: "Fig. 1B" should read "Fig. 1A" p. 287, 1.29: "Fig. 1C" should read "Fig. 1B" 2~6 I)ETEltS AND LEA r1IERS 100 '0ao 70 60 50 40 _u fJJ 0- % :::> 0­ 0­ c W... '" 100 '0 ao 6070 ~ 50 ,..-p 0, 40 ~/~::~2::S:~g3:::::::::~~ 30 100 0 • • 90 ~ eo 70 • •0 • ..--::,~'r ." ~ ~ ~ , 50 '''/ ... • "'- .. "• '0 ~- --.., -.. c, , " JO 10 20 30 40 50 60 70 ao '0 HOURS FIG. I. Atlaplive response of M. rt/cemo.ms strains to drugs. Early ex.ponential cultures were split at time 0 am.I challenged with drugs. fA) WilJAype strain: (8) cycloheximide constitutively resistant mutanl COR 3A: tel cycloheximide con~thutively resistant mutant eRG 2A: IDl cyclohe:ximide non~ adaptive mutant NAD 67. Culture control. no drugs ulhled \el; cycloheximitle. 100 J.Lglml (A): lri~ chouermin. 5.0 ",glml (lIl: amphotericin B. 0.4 ",glml tal. tants. Early exponential cultures of each As previously described (Leathers and strain were split at time 0 am! challenged Sypherd, (985), wild-type M, racemosliS with cycloheximide (100 flog/mil. trichoder­ adapted to initially inhibitory concentra­ min (5.0 flog/mi, or amphotcricin B (0.'1 tions of drugs after a lag period charactcr­ flog/mi). istic for each drug at a particular conccn- DRUG ADAPTATION MUTANTS OF M. nll'l'1I/1I.\/1.\ 287 tration (Fig. IA). Auapteu growth rates latcd as llllnauaptive to cycloheximiue. As were also characteristic for eaeh urug. but shown in Fig. ID. NAD 67 also failed to not strongly uepenuent on initial urug con­ recover from either trichodermin or ampho­ centrations. tericin B after more than 140 h. at which As shown in Fig. 1B, mutant strain COR time cultures were found to he sterile. The 3A grew without lag in medium containing pleiotropic nature of NAD 67 further sup­ 100 J.Lg/ml cycloheximide. Moreover. COR ports the conclusion that dissimilar drugs 3A showed early resistance to all three test share at least some common steps in phe­ drugs.
Load more

Recommended publications
  • Development of a Single Tube Multiplex Real-Time PCR to Detect the Most Clinically Relevant Mucormycetes Species
    ORIGINAL ARTICLE MYCOLOGY Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species L. Bernal-Martı´nez*, M. J. Buitrago*, M. V. Castelli, J. L. Rodriguez-Tudela and M. Cuenca-Estrella Servicio de Micologı´a, Centro Nacional de Microbiologı´a, Instituto de Salud Carlos III, Madrid, Spain Abstract Mucormycetes infections are very difficult to treat and a delay in diagnosis could be fatal for the outcome of the patient. A molecular diagnostic technique based on Real Time PCR was developed for the simultaneous detection of Rhizopus oryzae, Rhizopus microsporus and the genus Mucor spp. in both culture and clinical samples. The methodology used was Molecular beacon species-specific probes with an internal control. This multiplex real-time PCR (MRT-PCR) was tested in 22 cultured strains and 12 clinical samples from patients suf- fering from a proven mucormycosis. Results showed 100% specificity and a detection limit of 1 fg of DNA per microlitre of sample. The sensitivity was 100% for clinical cultured strains and for clinical samples containing species detected by the PCR assay. Other mu- cormycetes species were not detected in clinical samples. This technique can be useful for clinical diagnosis and further studies are war- ranted. Keywords: Mucormycetes, multiplex real time, fungal invasive infection Original Submission: 21 March 2012; Revised Submission: 29 May 2012; Accepted: 14 June 2012 Editor: E. Roilides Article published online: 28 August 2012 Clin Microbiol Infect 2013; 19: E1–E7 10.1111/j.1469-0691.2012.03976.x caspofungin [5] for the treatment of invasive aspergillosis, as Corresponding author: L.
    [Show full text]
  • On Mucoraceae S. Str. and Other Families of the Mucorales
    ZOBODAT - www.zobodat.at Zoologisch-Botanische Datenbank/Zoological-Botanical Database Digitale Literatur/Digital Literature Zeitschrift/Journal: Sydowia Jahr/Year: 1982 Band/Volume: 35 Autor(en)/Author(s): Arx Josef Adolf, von Artikel/Article: On Mucoraceae s. str. and other families of the Mucorales. 10-26 ©Verlag Ferdinand Berger & Söhne Ges.m.b.H., Horn, Austria, download unter www.biologiezentrum.at On Mucoraceae s. str. and other families of the Mucorales J. A. VON ARX Centraalbureau voor Schimmelcultures, Baarn, Netherlands*) Summary. — The Mucoraceae are redefined and contain mainly the genera Mucor, Circinomucor gen. nov., Zygorhynchus, Micromucor comb, nov., Rhizomucor and Umbelopsis char, emend. Mucor s. str. contains taxa with black, verrucose, scaly or warty zygo- spores (or azygospores), unbranched or only slightly branched sporangiophores, spherical, pigmented sporangia with a clavate or obclavate columolla, and elongate, ellipsoidal sporangiospores. Typical species are M. mucedo, M. flavus, M. recurvus and M. hiemalis. Zygorhynchus is separated from Mucor by black zygospores with walls covered with conical, often furrowed protuberances, small sporangia with a spherical or oblate columella, and small, spherical or rod-shaped sporangio- spores. Some isogamous or agamous species are transferred from Mucor to Zygorhynchus. Circinomucor is introduced for Mucor circinelloides, M. plumbeus, M. race- mosus and their relatives. The genus is characterized by cinnamon brown zygospores covered with starfish-like projections, racemously or sympodially branched sporangiophores, spherical sporangia with a clavate or ovate columella and small, spherical or broadly ellipsoidal sporangiospores. Micromucor is based on Mortierclla subg. Micromucor and is close to Mucor. The genus is characterized by volvety colonies, small, light sporangia with an often reduced columella and small, subspherical sporangiospores.
    [Show full text]
  • Diversity and Control of Spoilage Fungi in Dairy Products: an Update
    microorganisms Review Diversity and Control of Spoilage Fungi in Dairy Products: An Update Lucille Garnier 1,2 ID , Florence Valence 2 and Jérôme Mounier 1,* 1 Laboratoire Universitaire de Biodiversité et Ecologie Microbienne (LUBEM EA3882), Université de Brest, Technopole Brest-Iroise, 29280 Plouzané, France; lucille.garnier@univ-brest.fr 2 Science et Technologie du Lait et de l’Œuf (STLO), AgroCampus Ouest, INRA, 35000 Rennes, France; florence.valence-bertel@inra.fr * Correspondence: jerome.mounier@univ-brest.fr; Tel.: +33-(0)2-90-91-51-00; Fax: +33-(0)2-90-91-51-01 Received: 10 July 2017; Accepted: 25 July 2017; Published: 28 July 2017 Abstract: Fungi are common contaminants of dairy products, which provide a favorable niche for their growth. They are responsible for visible or non-visible defects, such as off-odor and -flavor, and lead to significant food waste and losses as well as important economic losses. Control of fungal spoilage is a major concern for industrials and scientists that are looking for efficient solutions to prevent and/or limit fungal spoilage in dairy products. Several traditional methods also called traditional hurdle technologies are implemented and combined to prevent and control such contaminations. Prevention methods include good manufacturing and hygiene practices, air filtration, and decontamination systems, while control methods include inactivation treatments, temperature control, and modified atmosphere packaging. However, despite technology advances in existing preservation methods, fungal spoilage is still an issue for dairy manufacturers and in recent years, new (bio) preservation technologies are being developed such as the use of bioprotective cultures. This review summarizes our current knowledge on the diversity of spoilage fungi in dairy products and the traditional and (potentially) new hurdle technologies to control their occurrence in dairy foods.
    [Show full text]
  • Mucormycosis in Immunocompetent Patients: a Case-Series of Patients With
    International Journal of Infectious Diseases 15 (2011) e533–e540 Contents lists available at ScienceDirect International Journal of Infectious Diseases jou rnal homepage: www.elsevier.com/locate/ijid Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature a, a a a a b Michele D. Mignogna *, Giulio Fortuna , Stefania Leuci , Daniela Adamo , Elvira Ruoppo , Maria Siano , c Umberto Mariani a Oral Medicine Unit, Department of Odontostomatological and Maxillo-facial Science of the School of Medicine and Surgery, Federico II University of Naples; Naples, Italy b Department of Biomorphological and Functional Sciences, Pathology Section of the School of Medicine and Surgery, Federico II University of Naples, Naples, Italy c Oral Medicine Unit, Department of Odontostomatology, ‘‘Ospedali Riuniti di Bergamo’’, Bergamo, Italy A R T I C L E I N F O S U M M A R Y Article history: Objectives: To review the current literature on mucormycosis in immunocompentent/otherwise healthy Received 12 March 2010 individuals, to which five new cases with maxillary sinus involvement have been added. Received in revised form 29 August 2010 Methods: We searched in the PudMed database all articles in the English language related to human Accepted 24 February 2011 infections caused by fungi of the order Mucorales, in immunocompetent/otherwise healthy patients, starting from January 1978 to June 2009. In addition, we updated the literature by reporting five new Keywords: cases diagnosed and treated at the oral medicine unit of our institution. Zygomycosis Results: The literature review showed at least 126 articles published from 35 different countries in the Phycomycosis world, to a total of 212 patients described.
    [Show full text]
  • A Novel Resistance Pathway for Calcineurin Inhibitors in the Human
    bioRxiv preprint doi: https://doi.org/10.1101/834143; this version posted December 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 A novel resistance pathway for calcineurin inhibitors in the human 2 pathogenic Mucorales Mucor circinelloides 3 4 Sandeep Vellanki1, R. Blake Billmyre2, 3, Alejandra Lorenzen1, Micaela Campbell1, 5 Broderick Turner1, Eun Young Huh1, Joseph Heitman3, and Soo Chan Lee1# 6 7 1South Texas Center for Emerging Infectious Diseases (STCEID), Department of 8 Biology, The University of Texas at San Antonio, San Antonio, TX. 9 2Current address: Stowers Institute for Medical Research, Kansas City, MO. 10 3Department of Molecular Genetics and Microbiology, Duke University Medical Center, 11 Durham, NC. 12 13 #Corresponding author: 14 Soo Chan Lee, Ph.D. 15 1 UTSA Circle, 16 South Texas Center for Emerging Infectious Diseases (STCEID), 17 Department of Biology, 18 University of Texas at San Antonio, San Antonio, TX 78249, USA 19 Email: soochan.lee@utsa.edu 20 Phone: (210) 458-5398 21 22 (Word count: Abstract: 446; Text: 4821) 23 Running title – Resistance to calcineurin inhibitors in Mucorales 1 bioRxiv preprint doi: https://doi.org/10.1101/834143; this version posted December 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 24 Abstract 25 Mucormycosis is an emerging lethal fungal infection in immunocompromised 26 patients. Mucor circinelloides is a causal agent of mucormycosis and serves as a model 27 system to understand genetics in Mucorales.
    [Show full text]
  • Species Identification of Clinical Zygomycetes Isolates by Automated Rep-PCR and DNA Sequencing Diversilab 44Th General Meeting, Washington DC, USA M
    Poster # D-466 Interscience Conference on Antimicrobial Agents and Chemotherapy Species Identification of Clinical Zygomycetes Isolates by Automated rep-PCR and DNA Sequencing DiversiLab 44th General Meeting, Washington DC, USA M. HEALY 1, D. WALTON 1, K. REECE 1, M. LISING 1, T. BITTNER 1, S. FRYE1, D. P. KONTOYIANNIS 2 www.bacbarcodes.com October 30 – November 2, 2004 Bacterial Barcodes - Spectral Genomics, Inc (1) and The University of Texas MD Anderson Cancer Center, Houston, TX (2) www.mdanderson.org Figure 1. Automated rep-PCR process Figure 2. ITS Sequence BLAST results 94ºC for 2 min, 35 cycles of denaturation at 92ºC for 30 sec, annealing at 50ºC for 30 sec, extension at 70ºC for 90 sec, and a final ABSTRACT ITS Sequence NCBI BLAST Results extension at 70ºC for 3 min. Detection and analysis of rep-PCR products were implemented using the DiversiLab System in which rep-PCR primers rep-PCR primers bind to many key Genus Organism Accession# SS the amplified fragments were separated and detected using microfluidics chips with the Agilent 2100 Bioanalyzer (Agilent Background: Human zygomycosis, an emerging and severe invasive mold infection, is caused by members of the class Zygomycetes, specific repetitive sequences interspersed throughout the Figure 3. Consensus dendrogram,1 whichMucor includes a Mucortotal circinelloides of 67 isolates, comparinggb|AY213658.1| clinical 93.75 genome Technologies, Palo Alto, CA), and analysis was performed with the DiversiLab software version 2.1.66. Reports included the order Mucorales; among these, isolates belonging to the genera Mucor, Rhizopus, Rhizomucor and Cunninghamella have been most genome 2 Mucor Mucor circinelloides gb|AY213658.1| 96.64 and environmental isolates to the Burkholderia library.
    [Show full text]
  • Descriptions of Medical Fungi
    DESCRIPTIONS OF MEDICAL FUNGI THIRD EDITION (revised November 2016) SARAH KIDD1,3, CATRIONA HALLIDAY2, HELEN ALEXIOU1 and DAVID ELLIS1,3 1NaTIONal MycOlOgy REfERENcE cENTRE Sa PaTHOlOgy, aDElaIDE, SOUTH aUSTRalIa 2clINIcal MycOlOgy REfERENcE labORatory cENTRE fOR INfEcTIOUS DISEaSES aND MIcRObIOlOgy labORatory SERvIcES, PaTHOlOgy WEST, IcPMR, WESTMEaD HOSPITal, WESTMEaD, NEW SOUTH WalES 3 DEPaRTMENT Of MOlEcUlaR & cEllUlaR bIOlOgy ScHOOl Of bIOlOgIcal ScIENcES UNIvERSITy Of aDElaIDE, aDElaIDE aUSTRalIa 2016 We thank Pfizera ustralia for an unrestricted educational grant to the australian and New Zealand Mycology Interest group to cover the cost of the printing. Published by the authors contact: Dr. Sarah E. Kidd Head, National Mycology Reference centre Microbiology & Infectious Diseases Sa Pathology frome Rd, adelaide, Sa 5000 Email: sarah.kidd@sa.gov.au Phone: (08) 8222 3571 fax: (08) 8222 3543 www.mycology.adelaide.edu.au © copyright 2016 The National Library of Australia Cataloguing-in-Publication entry: creator: Kidd, Sarah, author. Title: Descriptions of medical fungi / Sarah Kidd, catriona Halliday, Helen alexiou, David Ellis. Edition: Third edition. ISbN: 9780646951294 (paperback). Notes: Includes bibliographical references and index. Subjects: fungi--Indexes. Mycology--Indexes. Other creators/contributors: Halliday, catriona l., author. Alexiou, Helen, author. Ellis, David (David H.), author. Dewey Number: 579.5 Printed in adelaide by Newstyle Printing 41 Manchester Street Mile End, South australia 5031 front cover: Cryptococcus neoformans, and montages including Syncephalastrum, Scedosporium, Aspergillus, Rhizopus, Microsporum, Purpureocillium, Paecilomyces and Trichophyton. back cover: the colours of Trichophyton spp. Descriptions of Medical Fungi iii PREFACE The first edition of this book entitled Descriptions of Medical QaP fungi was published in 1992 by David Ellis, Steve Davis, Helen alexiou, Tania Pfeiffer and Zabeta Manatakis.
    [Show full text]
  • Updates on the Taxonomy of Mucorales with an Emphasis on Clinically Important Taxa
    Journal of Fungi Review Updates on the Taxonomy of Mucorales with an Emphasis on Clinically Important Taxa Grit Walther 1,*, Lysett Wagner 1 and Oliver Kurzai 1,2 1 German National Reference Center for Invasive Fungal Infections, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute, 07745 Jena, Germany; Lysett.Wagner@hki-jena.de (L.W.); okurzai@hygiene.uni-wuerzburg.de (O.K.) 2 Institute for Hygiene and Microbiology, University of Würzburg, 97080 Würzburg, Germany * Correspondence: Grit.Walther@leibniz-hki.de; Tel.: +49-3641-5321038 Received: 17 September 2019; Accepted: 11 November 2019; Published: 14 November 2019 Abstract: Fungi of the order Mucorales colonize all kinds of wet, organic materials and represent a permanent part of the human environment. They are economically important as fermenting agents of soybean products and producers of enzymes, but also as plant parasites and spoilage organisms. Several taxa cause life-threatening infections, predominantly in patients with impaired immunity. The order Mucorales has now been assigned to the phylum Mucoromycota and is comprised of 261 species in 55 genera. Of these accepted species, 38 have been reported to cause infections in humans, as a clinical entity known as mucormycosis. Due to molecular phylogenetic studies, the taxonomy of the order has changed widely during the last years. Characteristics such as homothallism, the shape of the suspensors, or the formation of sporangiola are shown to be not taxonomically relevant. Several genera including Absidia, Backusella, Circinella, Mucor, and Rhizomucor have been amended and their revisions are summarized in this review. Medically important species that have been affected by recent changes include Lichtheimia corymbifera, Mucor circinelloides, and Rhizopus microsporus.
    [Show full text]
  • Table S1. Characteristics of Repurposed Drugs/Compounds for Control of Fungal Pathogens. 1 Compounds Original Functions Target F
    Table S1. Characteristics of repurposed drugs/compounds for control of fungal pathogens. 1 Repurposing methods; Compounds Original functions Target fungi References cellular processes affected A. IN SILICO, COMPUTATIONAL Computational chemogenomics; Vistusertib, Anti-neoplastic drug Paracoccidioides species fungal phosphatidylinositol 3-kinase [15] BGT-226 candidates (TOR2) Candida albicans, Candida glabrata, Candida tropicalis, Candida dubliniensis, Candida parapsilosis, Aspergillus fumigatus, Aspergillus flavus, Rhizopus oryzae, Rhizopus microspores, Rhizomucor pusillus, Computational, Docking fluvastatin Rhizomucor miehei, Mucor racemosus, with cytochrome P450 (CYP51) Fluvastatin Anti-high cholesterol & [18,19] Mucor mucedo, Mucor circinelloides, model; triglycerides (blood) Absidia corymbifera, Absidia glauca, inhibition of growth and biofilm Trichophyton mentagrophytes, formation Trichophyton rubrum, Microsporum canis, Microsporum gypseum, Paecilomyces variotii, Syncephalastrum racemosum, Pythium insidiosum Ligand-based virtual screening, C. albicans, C. parapsilosis, Plant chorismate mutase homology modelling, molecular [16] Abscisic acid Aspergillus niger, inhibitor docking; T. rubrum, Trichophyton mentagrophytes chorismate mutase Homology modeling and molecular docking; P. insidiosum, Candida species, putative aldehyde dehydrogenase Disulfiram Treatment of alcoholism Cryptococcus species, A. fumigatus, [17,22] and urease activities, Histoplasma capsulatum bind/inactivate multiple proteins of P. insidiosum Raltegravir (MDDR, In
    [Show full text]
  • Antifungal Activity of Statins and Their Interaction with Amphotericin B Against Clinically Important Zygomycetes
    Acta Biologica Hungarica 61(3), pp. 356–365 (2010) DOI: 10.1556/ABiol.61.2010.3.11 ANTIFUNGAL ACTIVITY OF STATINS AND THEIR INTERACTION WITH AMPHOTERICIN B AGAINST CLINICALLY IMPORTANT ZYGOMYCETES L. GALGÓCZY*, GYÖNGYI LUKÁCS, ILDIKÓ NYILASI, T. PAPP and CS. VÁGVÖLGYI Department of Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary (Received: October 28, 2009; accepted: December 28, 2009) The in vitro antifungal activity of different statins and the combinations of the two most effective ones (fluvastatin and rosuvastatin) with amphotericin B were investigated in this study on 6 fungal isolates representing 4 clinically important genera, namely Absidia, Rhizomucor, Rhizopus and Syncephalastrum. The antifungal effects of statins revealed substantial differences. The synthetic statins proved to be more effective than the fungal metabolites. All investigated strains proved to be sensitive to fluvastatin. Fluvastatin and rosuvastatin acted synergistically and additively with amphotericin B in inhibiting the fungal growth in clinically available concentration ranges. Results suggest that statins combined with amphotericin B have a therapeutic potential against fungal infections caused by Zygomycetes species. Keywords: Statin – amphotericin B – Zygomycetes – drug interaction – synergism INTRODUCTION Various members of the class Zygomycetes are frequently isolated agents of mycotic diseases caused by non-Aspergillus moulds [26–28, 36]. Over the past decade, case number of zygomycosis (the opportunistic fungal infection caused by Zygomycetes fungi) has shown an increasing tendency in immunocompromised patients and per- sons having diabetes mellitus or burn injuries [5, 28, 30, 38]. Unfortunately, these fungi have a substantial intrinsic resistance to most of the widely used antifungal drugs (e.g. azoles) and show high MIC values for several other agents in in vitro tests [1, 32].
    [Show full text]
  • Antifungal Drug Repurposing
    antibiotics Perspective Antifungal Drug Repurposing Jong H. Kim 1,* , Luisa W. Cheng 1, Kathleen L. Chan 1, Christina C. Tam 1, Noreen Mahoney 1, Mendel Friedman 2, Mikhail Martchenko Shilman 3 and Kirkwood M. Land 4 1 Foodborne Toxin Detection and Prevention Research Unit, Western Regional Research Center, Agricultural Research Service, United States Department of Agriculture, Albany, CA 94710, USA; luisa.cheng@usda.gov (L.W.C.); kathy.chan@usda.gov (K.L.C.); christina.tam@usda.gov (C.C.T.); noreen.mahoney@usda.gov (N.M.) 2 Healthy Processed Foods Research Unit, Western Regional Research Center, Agricultural Research Service, United States Department of Agriculture, Albany, CA 94710, USA; mendel.friedman@usda.gov 3 Henry E. Riggs School of Applied Life Sciences, Keck Graduate Institute, Claremont, CA 91711, USA; mikhail_shilman@kgi.edu 4 Department of Biological Sciences, University of the Pacific, Stockton, CA 95211, USA; kland@pacific.edu * Correspondence: jongheon.kim@usda.gov; Tel.: +1-510-559-5841 Received: 17 September 2020; Accepted: 13 November 2020; Published: 15 November 2020 Abstract: Control of fungal pathogens is increasingly problematic due to the limited number of effective drugs available for antifungal therapy. Conventional antifungal drugs could also trigger human cytotoxicity associated with the kidneys and liver, including the generation of reactive oxygen species. Moreover, increased incidences of fungal resistance to the classes of azoles, such as fluconazole, itraconazole, voriconazole, or posaconazole, or echinocandins, including caspofungin, anidulafungin, or micafungin, have been documented. Of note, certain azole fungicides such as propiconazole or tebuconazole that are applied to agricultural fields have the same mechanism of antifungal action as clinical azole drugs.
    [Show full text]
  • Mold Allergy Test
    Requisition #: Physician Name: Patient Name: Date of Collection: Date of Birth: Time of Collection: Gender: Print Date: Dec 16, 2020 Mold Allergy Test (13) IU/ml IgE Molds Indoor Alternaria Tenuis 30.000 Reactivity Summary Very High Aspergillus Fumigatus 30.000 Alternaria Tenuis Bipolaris Spicifera 30.000 Aspergillus Fumigatus Candida Albicans 30.000 Bipolaris Spicifera Cladosporium Herbarum 30.000 Candida Albicans Epicoccum Purpurascens 30.000 Cladosporium Herbarum Fusarium Moniliforme 30.000 Epicoccum Purpurascens Fusarium Oxysporum 30.000 Fusarium Moniliforme Helminthosporium Halodes 30.000 Fusarium Oxysporum Mucor Racemosus 30.000 Helminthosporium Halodes Penicillium Notatum 30.000 Mucor Racemosus Phoma Betae 30.000 Penicillium Notatum Stemphylium Botryosum 30.000 Phoma Betae Stemphylium Botryosum - Negative <0.05 Class I 0.08-0.149 Class III 0.5-2.499 Class V 12.5-62.499 Class II Class IV Class VI * Equivocal 0.05-0.079 0.15-0.499 2.5-12.499 >62.5 The reagents and instrument used in this test have been approved by the U.S. Food and Drug Administration. 3:50:01PM Requisition #: Physician Name: Patient Name: Date of Collection: Date of Birth: Time of Collection: Gender: Print Date: Dec 16, 2020 MOLD ENVIRONMENT AND MYCOTOXINS PRODUCED Penicillium notatum (chrysogenum) Found in food and damp buildings. Can cause respiratory conditions like pneumonia, localized granulomas,fungus balls, asthma and systemic infections like endophthalmitis. Species of this mold produce the mycotoxins gliotoxin, ochratoxin, sterigmatocystin, citrinin, and mycophenolic acid, which are measured in the MycoTOX Profile. Cladosporium herbarum Common outdoor mold found in 70% of homes tested in the US.
    [Show full text]